Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - NET CHANGE IN CASH
Net Change in Cash ALNY - Alnylam Pharmaceuticals, Inc.
154 M
LAST VALUE
82.04%
2 YEAR CAGR
3.90%
5 YEAR CAGR
21.46%
10 YEAR CAGR